In evaluating suspected heart failure, which statement about troponin testing is true?

In evaluating suspected heart failure, which statement about troponin testing is true?

• A. Troponin testing is always required
• B. Troponin testing is optional
• C. Troponin testing replaces BNP
• D. Troponin testing should be performed only if CK-MB elevated

Answer: (B)

Troponin testing in suspected heart failure is about detecting myocardial injury and helping with risk stratification when there is a concern for concurrent ischemia, not diagnosing heart failure itself. Because heart failure diagnosis relies mainly on symptoms, exam findings, and BNP or NT-proBNP levels, troponin is not mandatory in every case. Its elevation can indicate worse prognosis and can guide urgent management if there’s suspicion of acute coronary involvement, but a normal troponin does not rule out heart failure. Troponin does not replace BNP, since they reflect different processes—myocardial injury versus ventricular stretch/volume status. And troponin testing is not contingent on CK-MB elevations; modern practice uses troponin for its own diagnostic and prognostic value, independently of CK-MB.

Troponin testing in suspected heart failure is about detecting myocardial injury and helping with risk stratification when there is a concern for concurrent ischemia, not diagnosing heart failure itself. Because heart failure diagnosis relies mainly on symptoms, exam findings, and BNP or NT-proBNP levels, troponin is not mandatory in every case. Its elevation can indicate worse prognosis and can guide urgent management if there’s suspicion of acute coronary involvement, but a normal troponin does not rule out heart failure. Troponin does not replace BNP, since they reflect different processes—myocardial injury versus ventricular stretch/volume status. And troponin testing is not contingent on CK-MB elevations; modern practice uses troponin for its own diagnostic and prognostic value, independently of CK-MB.